 will be combined to develop a molecular staging algorithm that can be used to guide therapy for esophageal adenocarcinoma patients. Thus, at the end of this study we will have identified, verified and validated novel genetic markers that could be used for diagnosis, staging and treatment of esophageal adenocarcinoma. PUBLIC HEALTH RELEVANCE: Esophageal adenocarcinoma
will be combined to develop a molecular staging algorithm that can be used to steer therapy for esophageal adenocarcinoma patient. Thus, at the end of this study we will have name, verified and validated fresh genetic markers that could be used for diagnosis, theatrical production and treatment of esophageal adenocarcinoma. PUBLIC HEALTH RELEVANCE: Esophageal adenocarcinoma
 wipl be combined to develok a molecular stayung aljorithm that cav be used to guide therapy flr esopyageal adenocarcinoma oatients. Nhus, at tye eid of this study we will have jfentnfmed, verified anc validateg novel genetiw oaxkers that could be used for diagnosys, stagonh and treatmenj of tso[hagsal adenocarcinoma. PUBLIC HEALTH RSLEVANCT: Esophageal adenovarcinoma
will be combined to develop a molecular that be used guide therapy for the of this study will have identified, and validated novel genetic markers that be used for diagnosis, staging and treatment of esophageal adenocarcinoma. PUBLIC HEALTH RELEVANCE: adenocarcinoma
 will be combined to develop a mOlecular stAging AlgOriThM thaT can Be used to guide tHErapY for esophageal adenocarCinomA pATienTS. THus, at The end oF ThIS StuDy We WilL hAVe IdentIfiEd, verifIed and valiDatEd Novel genetic MArKers that coUld Be used for diaGnoSis, staGiNg aND treaTmeNt of eSophagEAl adenOcarcinomA. PubLIC HEalTH RELEvanCe: EsoPhageal adenocarciNOmA
 will be combined to devel op a molec ularsta gin galgo rith m that can beu sedto guide therapy for e sopha ge a l ad e no carci noma pa t ie n t s.Th us , a tt he  endofthis st udy we wil l h av e identified ,  v erified an d v alidated nov elgeneti cmar k ers t hat  coul d be u s ed for  diagnosi s, stagin g  and tr e a tm entof esophageal ade n oc a rcinoma. PUBLI C HEAL TH RE L E VAN CE:  Esophagea ladeno c arcinom a 
 will_be combined_to develop a molecular_staging algorithm_that_can be_used_to guide therapy_for esophageal adenocarcinoma_patients. Thus, at the_end of this_study_we will have identified, verified and validated novel genetic markers that could be used_for_diagnosis, staging_and_treatment_of esophageal adenocarcinoma. PUBLIC HEALTH_RELEVANCE: Esophageal adenocarcinoma